(E)-3-(Phenylsulfonyl)acrylic acid
(E)-3-(Phenylsulfonyl) acrylic acid is a sulfonyl acrylic acid intermediate that can be used for the preparation of NLRP3 inflammasome inhibitors.
For research use only. We do not sell to patients.
- CAS No.: 711-29-5
- Formula: C9H8O4S
- Molecular Weight:212.22
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
(E)-3-(Phenylsulfonyl) acrylic acid (compound 4f) serves as an intermediate to prepare the NLRP3 inflammasome inhibitor compound 28a[1] via TBTU-mediated amide condensation with 4-(2-aminoethyl) benzenesulfonamide.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 711-29-5
-
Molecular Weight 212.22
-
Formula C9H8O4S
-
SMILES
S(/C=C/C(O)=O)(=O)(=O)C1=CC=CC=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)